Axonics Inc (AXNX)
67.24
+0.16
(+0.24%)
USD |
NASDAQ |
May 03, 16:00
67.24
0.00 (0.00%)
After-Hours: 20:00
Axonics Cash from Investing (Quarterly): 138.23M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 138.23M |
| December 31, 2023 | -37.92M |
| September 30, 2023 | -11.05M |
| June 30, 2023 | -68.62M |
| March 31, 2023 | 0.694M |
| December 31, 2022 | -10.03M |
| September 30, 2022 | -99.40M |
| June 30, 2022 | -10.63M |
| March 31, 2022 | -0.291M |
| December 31, 2021 | -1.084M |
| September 30, 2021 | -0.684M |
| June 30, 2021 | -0.37M |
| March 31, 2021 | -140.86M |
| Date | Value |
|---|---|
| December 31, 2020 | -1.023M |
| September 30, 2020 | -0.648M |
| June 30, 2020 | -0.553M |
| March 31, 2020 | 11.88M |
| December 31, 2019 | 12.34M |
| September 30, 2019 | 17.46M |
| June 30, 2019 | 11.44M |
| March 31, 2019 | 4.049M |
| December 31, 2018 | -48.12M |
| September 30, 2018 | 3.516M |
| June 30, 2018 | -15.29M |
| March 31, 2018 | -0.161M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-140.86M
Minimum
Mar 2021
138.23M
Maximum
Mar 2024
-9.557M
Average
-0.666M
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp | -285.00M |
| Cutera Inc | -2.599M |
| Stereotaxis Inc | 0.00 |
| Electromed Inc | -0.087M |
| Myomo Inc | 2.294M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.236M |
| Cash from Financing (Quarterly) | 0.248M |
| Free Cash Flow | -16.29M |
| Free Cash Flow Per Share (Quarterly) | -0.2414 |
| Free Cash Flow to Equity (Quarterly) | -12.30M |
| Free Cash Flow to Firm (Quarterly) | -12.30M |
| Free Cash Flow Yield | -0.49% |